6-36678211-G-C

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001291549.3(CDKN1A):​c.97+278G>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.232 in 277,810 control chromosomes in the GnomAD database, including 7,018 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.22 ( 3667 hom., cov: 32)
Exomes 𝑓: 0.25 ( 3351 hom. )

Consequence

CDKN1A
NM_001291549.3 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 2.09
Variant links:
Genes affected
CDKN1A (HGNC:1784): (cyclin dependent kinase inhibitor 1A) This gene encodes a potent cyclin-dependent kinase inhibitor. The encoded protein binds to and inhibits the activity of cyclin-cyclin-dependent kinase2 or -cyclin-dependent kinase4 complexes, and thus functions as a regulator of cell cycle progression at G1. The expression of this gene is tightly controlled by the tumor suppressor protein p53, through which this protein mediates the p53-dependent cell cycle G1 phase arrest in response to a variety of stress stimuli. This protein can interact with proliferating cell nuclear antigen, a DNA polymerase accessory factor, and plays a regulatory role in S phase DNA replication and DNA damage repair. This protein was reported to be specifically cleaved by CASP3-like caspases, which thus leads to a dramatic activation of cyclin-dependent kinase2, and may be instrumental in the execution of apoptosis following caspase activation. Mice that lack this gene have the ability to regenerate damaged or missing tissue. Multiple alternatively spliced variants have been found for this gene. [provided by RefSeq, Sep 2015]
DINOL (HGNC:53146): (damage induced long noncoding RNA)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.287 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CDKN1ANM_001291549.3 linkc.97+278G>C intron_variant Intron 2 of 3 NP_001278478.1 P38936
CDKN1ANM_001374509.1 linkc.97+278G>C intron_variant Intron 2 of 3 NP_001361438.1
CDKN1ANM_001374510.1 linkc.34+1641G>C intron_variant Intron 1 of 2 NP_001361439.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CDKN1AENST00000448526.6 linkc.-6+278G>C intron_variant Intron 2 of 3 3 ENSP00000409259.3 P38936
CDKN1AENST00000615513.4 linkc.-6+1687G>C intron_variant Intron 1 of 2 2 ENSP00000482768.1 P38936
DINOLENST00000643333.1 linkn.349C>G non_coding_transcript_exon_variant Exon 1 of 1
CDKN1AENST00000459970.1 linkn.189+278G>C intron_variant Intron 2 of 2 5

Frequencies

GnomAD3 genomes
AF:
0.218
AC:
33122
AN:
151958
Hom.:
3658
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.260
Gnomad AMI
AF:
0.0669
Gnomad AMR
AF:
0.199
Gnomad ASJ
AF:
0.264
Gnomad EAS
AF:
0.129
Gnomad SAS
AF:
0.299
Gnomad FIN
AF:
0.179
Gnomad MID
AF:
0.306
Gnomad NFE
AF:
0.202
Gnomad OTH
AF:
0.252
GnomAD4 exome
AF:
0.249
AC:
31368
AN:
125734
Hom.:
3351
Cov.:
0
AF XY:
0.262
AC XY:
18018
AN XY:
68818
show subpopulations
African (AFR)
AF:
0.319
AC:
894
AN:
2802
American (AMR)
AF:
0.200
AC:
1016
AN:
5074
Ashkenazi Jewish (ASJ)
AF:
0.289
AC:
926
AN:
3206
East Asian (EAS)
AF:
0.143
AC:
673
AN:
4696
South Asian (SAS)
AF:
0.329
AC:
8369
AN:
25402
European-Finnish (FIN)
AF:
0.210
AC:
1083
AN:
5146
Middle Eastern (MID)
AF:
0.265
AC:
129
AN:
486
European-Non Finnish (NFE)
AF:
0.230
AC:
16655
AN:
72538
Other (OTH)
AF:
0.254
AC:
1623
AN:
6384
Heterozygous variant carriers
0
1058
2116
3174
4232
5290
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Exome Hom
Variant carriers
0
134
268
402
536
670
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.218
AC:
33145
AN:
152076
Hom.:
3667
Cov.:
32
AF XY:
0.217
AC XY:
16111
AN XY:
74338
show subpopulations
African (AFR)
AF:
0.260
AC:
10767
AN:
41462
American (AMR)
AF:
0.198
AC:
3034
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.264
AC:
916
AN:
3470
East Asian (EAS)
AF:
0.129
AC:
665
AN:
5166
South Asian (SAS)
AF:
0.300
AC:
1445
AN:
4822
European-Finnish (FIN)
AF:
0.179
AC:
1895
AN:
10576
Middle Eastern (MID)
AF:
0.312
AC:
91
AN:
292
European-Non Finnish (NFE)
AF:
0.202
AC:
13723
AN:
67980
Other (OTH)
AF:
0.260
AC:
548
AN:
2110
Heterozygous variant carriers
0
1328
2656
3983
5311
6639
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Genome Hom
Variant carriers
0
348
696
1044
1392
1740
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.200
Hom.:
379
Bravo
AF:
0.218
Asia WGS
AF:
0.261
AC:
911
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.81
CADD
Benign
7.4
DANN
Benign
0.37
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs4151702; hg19: chr6-36645988; API